City of San Francisco Report issue

Government Phase 1 Phase 2 Phase 4
Founded: San Francisco CA United States (1776)

Organization Overview

First Clinical Trial
2004
NCT00076063
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bridge HIV, San Francisco Department of Public Health | Bridge HIV, SFDPH | Center for Public Health Research, San Francisco Department of Public Health | Director of Substance Use Research, San Francisco Department of Public Health | Director, Substance Use Division, San Francisco Department of Public Health | Phillip Coffin, MD, MIA | San Francisco Department of Public Health | San Francisco Dept. of Public Health | Substance Use Research Unit, San Francisco Department of Public Health

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amphetamine-Related Disorders (Phase 2)

Binge Drinking (Phase 2)

Cardiovascular Abnormalities (Phase 1)

Gonorrhea (Phase 4)

Hepatitis (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

HIV Infections (Phase 2)

Infections (Phase 4)

Sexually Transmitted Diseases (Phase 4)

Substance-Related Disorders (Phase 2)

Syphilis (Phase 4)

Vaccinia (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 21